The technology used for creating a mechanical connection between two vessels during coronary artery bypass graft surgery (CABG) may offer a promising alternative to more traditional suture-based anastomoses. The technology was developed by US company Cardica Inc.
Clinical trial results from multi-centre study of the trademarked C-Port distal anastomosis system indicate that the new technology may improve outcomes. The trial, involving over 100 patients, is being conducted at five heart centres in Germany and Switzerland.
The openness or patency (defined as presence of contrast media) of the vessels joined with the C-Port device at six months after the …
No comments:
Post a Comment